日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release

体外 CRISPR 筛选游离 DNA 发现细胞凋亡是游离 DNA 释放的主要介质

期刊:Communications Biology
影响因子:5.2
doi:10.1038/s42003-024-06129-1
Brad A Davidson, Adam X Miranda, Sarah C Reed, Riley E Bergman, Justin D J Kemp, Anvith P Reddy, Morgan V Pantone, Ethan K Fox, R Dixon Dorand, Paula J Hurley, Sarah Croessmann, Ben Ho Park
信号转导
细胞生物学
其它细胞
FCM
IF
IHC-P
WB
Apoptosis
发表日期：2024
文献求助 收藏

Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease

对筛状前列腺癌的单细胞分析揭示了侵袭性疾病的细胞内在途径和肿瘤微环境途径。

期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-022-33780-1
Hong Yuen Wong ，Quanhu Sheng ，Amanda B Hesterberg ，Sarah Croessmann ，Brenda L Rios ，Khem Giri ，Jorgen Jackson ，Adam X Miranda ，Evan Watkins ，Kerry R Schaffer ，Meredith Donahue ，Elizabeth Winkler ，David F Penson ，Joseph A Smith ，S Duke Herrell ，Amy N Luckenbaugh ，Daniel A Barocas ，Young J Kim ，Diana Graves ，Giovanna A Giannico ，Jeffrey C Rathmell ，Ben H Park ，Jennifer B Gordetsky ，Paula J Hurley
肿瘤微环境
肿瘤免疫
细胞生物学
前列腺癌
单细胞
肿瘤
发表日期：2022
文献求助 收藏

NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model

NOTCH1 PEST 结构域变体尽管在乳腺癌模型中具有独特的转化特性，但对标准护理治疗仍有反应

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.28200
Karen Cravero, Morgan V Pantone, Dong Ho Shin, Riley Bergman, Rory Cochran, David Chu, Daniel J Zabransky, Swathi Karthikeyan, Ian G Waters, Natasha Hunter, D Marc Rosen, Kelly Kyker-Snowman, W Brian Dalton, Berry Button, Dan Shinn, Hong Yuen Wong, Joshua Donaldson, Paula J Hurley, Sarah Croessmann,
信号转导
肿瘤
乳腺癌
WB
Notch
发表日期：2022
文献求助 收藏

Systemic inhibition of PTPN22 augments anticancer immunity

系统性抑制PTPN22可增强抗癌免疫力

期刊:Journal of Clinical Investigation
影响因子:13.3
doi:10.1172/JCI146950
Won Jin Ho ，Sarah Croessmann ，Jianping Lin ，Zaw H Phyo ，Soren Charmsaz ，Ludmila Danilova ，Aditya A Mohan ，Nicole E Gross ，Fangluo Chen ，Jiajun Dong ，Devesh Aggarwal ，Yunpeng Bai ，Janey Wang ，Jing He ，James M Leatherman ，Mark Yarchoan ，Todd D Armstrong ，Neeha Zaidi ，Elana J Fertig ，Joshua C Denny ，Ben H Park ，Zhong-Yin Zhang ，Elizabeth M Jaffee
免疫/内分泌
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

异常 FGFR 信号介导 ER+ 乳腺癌对 CDK4/6 抑制剂的耐药性

期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-019-09068-2
Luigi Formisano, Yao Lu, Alberto Servetto, Ariella B Hanker, Valerie M Jansen, Joshua A Bauer, Dhivya R Sudhan, Angel L Guerrero-Zotano, Sarah Croessmann, Yan Guo, Paula Gonzalez Ericsson, Kyung-Min Lee, Mellissa J Nixon, Luis J Schwarz, Melinda E Sanders, Teresa C Dugger, Marcelo Rocha Cruz, Amir B
信号转导
肿瘤
乳腺癌
IHC
WB
发表日期：2019
文献求助 收藏

Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer

联合阻断激活 ERBB2 突变和 ER 可导致 ER+/HER2 突变乳腺癌的综合致死率

期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-18-1544
Sarah Croessmann, Luigi Formisano, Lisa N Kinch, Paula I Gonzalez-Ericsson, Dhivya R Sudhan, Rebecca J Nagy, Aju Mathew, Eric H Bernicker, Massimo Cristofanilli, Jie He, Richard E Cutler Jr, Alshad S Lalani, Vincent A Miller, Richard B Lanman, Nick V Grishin, Carlos L Arteaga4
肿瘤
乳腺癌
发表日期：2019
文献求助 收藏

Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial

使用 Neratinib 联合氟维司群进行延长辅助治疗可阻断 ER/HER2 串扰并维持 ER+/HER2+ 乳腺癌的完全缓解：对 ExteNET 试验的影响

期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-18-1131
Dhivya R Sudhan #, Luis J Schwarz #, Angel Guerrero-Zotano, Luigi Formisano, Mellissa J Nixon, Sarah Croessmann, Paula I González Ericsson, Melinda Sanders, Justin M Balko, Francesca Avogadri-Connors, Richard E Cutler, Alshad S Lalani, Richard Bryce, Alan Auerbach, Carlos L Arteaga
肿瘤
乳腺癌
WB
发表日期：2019
文献求助 收藏

The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies

雌激素受体-α S118P 变异不会影响乳腺癌发病率或对内分泌疗法的反应

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-018-05087-7
Berry Button, Sarah Croessmann, David Chu, D Marc Rosen, Daniel J Zabransky, W Brian Dalton, Karen Cravero, Kelly Kyker-Snowman, Ian Waters, Swathi Karthikeyan, Eric S Christenson, Josh Donaldson, Tasha Hunter, Lauren Dennison, Cody Ramin, Betty May, Richard Roden, Dana Petry, Deborah K Armstrong, K
肿瘤
乳腺癌
WB
发表日期：2019
文献求助 收藏

PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K α Inhibitors

PIK3CA C2 结构域缺失会过度激活磷脂酰肌醇 3-激酶 (PI3K)，产生致癌基因依赖性，并且对 PI3K α 抑制剂极其敏感

期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-17-2141
Sarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, Gregory Sliwoski, Jie He, Rebecca Nagy, David Riddle, Ingrid A Mayer, Justin M Balko, Richard Lanman, Vincent A Miller, Lewis C Cantley, Jens Meiler, Carlos L Arteaga
信号转导
肿瘤
PI3K/Akt
发表日期：2018
文献求助 收藏

PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity

PIK3CA 突变和 TP53 变异共同增加癌症表型和肿瘤异质性

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-017-4147-2
Sarah Croessmann, Hong Yuen Wong, Daniel J Zabransky, David Chu, D Marc Rosen, Justin Cidado, Rory L Cochran, W Brian Dalton, Bracha Erlanger, Karen Cravero, Berry Button, Kelly Kyker-Snowman, Paula J Hurley, Josh Lauring, Ben Ho Park
肿瘤
发表日期：2017
文献求助 收藏